-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Amerikanscher Freiverkehr OTC oder "Pink Sheets"USDISIN GB00BRS65X63-
INDIVIOR PLCBörse Quotrix System der Börse DüsseldorfEURSymbol 2IV
-
INDIVIOR PLCBörse Gettex System der Börse MünchenEURSymbol 2IV
-
INDIVIOR PLCBörse Börse DüsseldorfEURSymbol 2IV
-
INDIVIOR PLCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 2IV
-
INDIVIOR PLCBörse Börse StuttgartEURSymbol 2IV
-
Indivior PLCBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"ISIN GB00BRS65X63 WKN: A12FHWUSDSymbol INDV
-
Indivior PLCBörse London Stock ExchangeISIN GB00BRS65X63 WKN: A12FHWSymbol INDV
-
GBpISIN GB00BRS65X63
-
EURSymbol 2IV
-
EURSymbol 2IV
-
EURSymbol 2IV
-
USD
-
USD
-
ISIN GB00BRS65X63
WKN A12FHW
Symbol INDV
Währung
USD
Börse
Amerikanscher Freiverkehr OTC oder "Pink Sheets" Zeitzone: America/New_York
Marktkapitalisierung
58.000.000
Mitarbeiter
900
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 1,73 EUR -0,40%
Aktionärsstruktur der Indivior PLC
Dir gefallen die Informationen zu Indivior PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Indivior PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Indivior PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Indivior PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
27 News & Informationen zur Indivior PLC Aktie
Addex Therapeutics : to Ring the Nasdaq Stock Market Closing Bell
Addex Therapeutics to Ring the Nasdaq Stock Market Closing Bell
Geneva, Switzerland and New York, February 3, 2020 – Addex Therapeutics Ltd , a clinical-stage pharmaceutical… | August 5, 2021
Addex Therapeutics : to Present at the Baader Helvea Swiss Equities Conference
Addex to Present at the Baader Helvea Swiss Equities Conference
Geneva, Switzerland, January 12, 2021 – Addex Therapeutics Ltd , a clinical-stage pharmaceutical company… | August 5, 2021
Addex Reports 2021 Half Year and Second Quarter Financial Results and Provides Corporate Update
Strong cash and cash equivalents position at June 30, 2021 of CHF18.1M ($19.6M)Pivotal dipraglurant PD-LID study initiatedJanssen Pharmaceuticals started…
Indivior PLC 2021 Q2 – Results – Earnings Call Presentation (OTCMKTS:INVVY)
The following slide deck was published by Indivior PLC in conjunction with their 2021 Q2 earnings call.
Indivior PLC (INVVY) CEO Mark Crossley on Q2 2021 Results – Earnings Call Transcript
Indivior PLC (OTCPK:INVVY) Q2 2021 Earnings Conference Call July 29, 2021 08:00 ET Company Participants Mark Crossley – Chief Executive Officer Ryan Preblick – Chief Financial Officer…
Press Release : Addex and Indivior Extend Research Collaboration on GABAB Positive Allosteric Modulators – Indivior Commits $4 Million of New Funding
Ad Hoc Announcement Pursuant to Art. 53 LR
Addex Therapeutics Ltd , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced… | July 29, 2021
Addex Therapeutics : to Present at Access to Giving Virtual Conference on July 14, 2021
Addex Therapeutics to Present at Access to Giving Virtual Conference on July 14, 2021
Geneva, Switzerland, July 7, 2021 – Addex Therapeutics , a clinical-stage pharmaceutical… | July 23, 2021
What Drug Companies Have Paid to Settle Claims Over U.S. Opioid Crisis
State attorneys general on Wednesday unveiled a $26 billion settlement with the three largest U.S. drug distributors and Johnson & Johnson to resolve
Factbox-Companies pay billions of dollars over role in U.S. opioid crisis By Reuters
Factbox-Companies pay billions of dollars over role in U.S. opioid crisis
JDP Capital Management 1H21 Commentary
Spotify (NYSE:SPOT) delivered remarkable progress in the first half of 2021 that turbocharged the platform's value proposition
HutchMed shares beat the rest of the LSE last week
HutchMed shares outperformed the rest of the LSE last week, according to Saxo Markets. Here is why the company's shares price rose to top the LSE.
Press Release : Addex Therapeutics to Present at Access to Giving Virtual Conference on July 14, 2021
Geneva, Switzerland, July 7, 2021 – Addex Therapeutics… | July 7, 2021
High street revival boosts JD Sports and Primark
Plus news on GlaxoSmithKline, BT and AO World
The Indivior share price soars to 3-year highs! Here’s what I’m doing now
The Indivior share price has jumped after the UK healthcare share hiked its full-year forecasts. Is now the time to buy the FTSE 250 firm?
Press Release : Addex, Stanford University and University of Copenhagen Publish mGlu2 Structure in Nature Using Addex Allosteric Modulators
Ad Hoc Announcement Pursuant to Art. 53 LR
— Data could enable acceleration of lead optimization using computer aided
drug discovery tools
— Addex existing mGlu2 positive… | July 1, 2021
European shares end lower but gain for a fifth straight month
European shares ended lower on Wednesday as investors locked in gains after a five-month winning streak, with concerns over an eventual spike in inflation and…
Shaky Futures Close Out Second Best First Half Since 1998
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
FTSE 100 slips as COVID-19 cases jump
-London's FTSE 100 slipped on Wednesday over concerns that a recent jump in coronavirus infections could hinder the pace of economic growth, taking the shine off what is likely to be a fifth straight… | June 30, 2021
FTSE 100 slips as COVID-19 cases jump
London’s FTSE 100 slipped on Wednesday over concerns that a recent jump in coronavirus infections in the UK could hinder the pace of economic growth, taking…
Indivior : Raises FY 2021 Guidance
Indivior Raises FY 2021 Guidance
This release contains inside information.
Slough, UK and Richmond, VA, June 30, 2021 – Indivior PLC today… | June 30, 2021
FTSE 100 to Open Lower After Mixed Asia, Subdued U.S. Sessions
FTSE 100 Set to Open Lower After Mixed Asia Trading 0639 GMT – The FTSE 100 looks set to open about 11 points lower at 7076, according to IG data, after mixed Asia trading and a marginally…
Addex Establishes At-The-Market ADS Equity Sale Program
Geneva, Switzerland, June 30, 2021 – Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today… | June 30, 2021
Press Release : Addex Therapeutics Initiates Pivotal Phase 2b/3 Study with Dipraglurant for Dyskinesia Associated with Parkinson's Disease
Geneva, Switzerland, June 29, 2021 – Addex Therapeutics Ltd , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that… | June 29, 2021
Addex to Present at the 20th Annual Needham Virtual Healthcare Conference
Geneva, Switzerland, April 13, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allo…
Opioid Use Disorder Market Worth USD 4.87 Billion at 8.7% CAGR by 2027 Backed by Increasing Number of Opioid Dependence Patients in North America
Pune, India, Jan. 13, 2021 (GLOBE NEWSWIRE) — The global opioid use disorder market is expected to experience exponential growth by reaching USD 4.87 …
Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter's Option to Purchase Additional Securities
Geneva, Switzerland, January 11, 2021 – Addex Therapeutics Ltd , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced… | January 11, 2021
Press Release: Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter's Option to Purchase Additional Securities
Geneva, Switzerland, January 11, 2021 — Addex Therapeutics… | January 11, 2021